• miR-18a, ALOXE3, and GBM Ferroptosis

  2026-09-30

  The reference study identifies a miR-18a/ALOXE3 axis that links lipid metabolism to ferroptosis resistance and migration in glioblastoma. Its findings position ALOXE3 as a mechanistic tumor-suppressive node and provide a framework for separating cell-death regulation from Gs-linked migration signaling in future cancer biology research.

• Metal-Free Carbon Nanozymes for ALP Detection

  2026-09-29

  The reference study develops a metal-free carbon-dot nanozyme assay for alkaline phosphatase (ALP), using pyrophosphate-controlled catalytic inhibition to generate a colorimetric turn-on signal. Its kinetic analysis identifies a noncompetitive pyrophosphate-binding site distinct from the principal nanozyme active site, enabling sensitive ALP measurement while reducing metal-ion interference.

• O6-Benzylguanine: Turning MGMT Into a Testable Liability

  2026-09-29

  A translational perspective on O6-Benzylguanine as a direct MGMT inhibitor, using recurrent glioblastoma biology to connect DNA repair inhibition, alkylating-agent sensitization, and experimental strategy.

• CD59–JAK2–STAT3 Signaling in Pancreatic Cancer

  2026-09-28

  A 2026 study identifies CD59 as a tumor cell-intrinsic driver of pancreatic cancer progression rather than only a complement-protective membrane protein. The work connects CD59 to JAK2–STAT3–CACNA1D signaling and shows that combined targeting of this axis with KRAS inhibition may limit adaptive growth responses.

• Melittin for GPCR Signaling in Glioblastoma Research

  2026-09-28

  Use Melittin as an acute G-protein signaling probe alongside genetic models of glioblastoma lipid metabolism—not as a stand-in for ALOXE3 manipulation. This workflow pairs short-timescale GPCR readouts with viability, ferroptosis-related, and migration assays to help separate pathway modulation from nonspecific cell injury.

• BI 2536: Selective PLK1 Inhibitor Evidence and Use

  2026-09-27

  BI 2536 is an ATP-competitive PLK1 inhibitor used to investigate mitosis and cancer biology. Product information reports subnanomolar PLK1 potency, while a peer-reviewed study used BI-2536 to examine PLK1-dependent regulation of mitotic checkpoint complex disassembly.

• Roscovitine: From CDK Biology to Translational Design

  2026-09-26

  A translational perspective on using Roscovitine (Seliciclib) to investigate CDK signaling, reversible cell-cycle arrest, and tumor models—while treating selectivity, assay design, and evidence boundaries as central experimental questions.

• DDI2–NFE2L1 Proteostasis Protects Against Ferroptosis

  2026-09-25

  The study shows that ferroptotic stress disrupts proteasome activity and triggers a compensatory NFE2L1 response that depends on DDI2-mediated cleavage. When this DDI2–NFE2L1 feedback pathway is impaired, cells accumulate ubiquitylated proteins and become more vulnerable to ferroptosis, including after nelfinavir treatment in the tested cellular models.

• O6-Benzylguanine: Reliable MGMT Inhibition Workflows

  2026-09-25

  Learn how O6-Benzylguanine (SKU B5974) can help researchers test MGMT-mediated resistance in cell viability and alkylating-agent experiments. This scenario-driven guide covers experimental controls, handling, interpretation, and product-selection considerations.

• H₂O₂, STOP1 Oxidation, and Aluminum Resistance

  2026-09-24

  This Arabidopsis study shows that elevated H₂O₂ can weaken aluminum resistance by oxidizing STOP1 and promoting its RAE1-associated degradation, while TRX1 can reverse STOP1 oxidation. The findings connect mitochondrial function and redox control to transcription-factor stability, offering a framework for investigating how oxidative stress shapes plant responses to aluminum.

• Data-Driven Design of Small-Molecule Libraries

  2026-09-24

  Moret et al. present a data-driven framework for comparing and designing small-molecule collections using selectivity, target coverage, cellular phenotypes, chemical structure, and other practical criteria. Applying it to existing kinase libraries led to LSP-OptimalKinase, while a separate mechanism-of-action collection was designed to cover 1,852 genes in the liganded genome.

• Viral RIPK3 Degradation Shapes Orthopoxvirus Inflammation

  2026-09-23

  Liu and colleagues identify vIRD, an orthopoxvirus protein that recruits host ubiquitination machinery to drive RIPK3 degradation and suppress necroptosis. Viral-genetic and mouse experiments connect this mechanism to virus replication, inflammation, and disease, while showing that its effects depend on host RIPK3–MLKL signaling.

• PSMA4 in Lung Adenocarcinoma: Causal Evidence

  2026-09-23

  The reference study integrates GWAS, cis-eQTL, cis-mQTL, colocalization, and functional experiments to prioritize PSMA4 as a lung adenocarcinoma candidate target. Its findings connect PSMA4 activity with proteasome-dependent p53 turnover, while also outlining how genetic evidence and orthogonal validation can guide cancer research workflows.

• TMJ Inflammation and Hippocampal Synaptic Pruning

  2026-09-22

  This study identifies a mechanistic link between temporomandibular joint inflammation, reduced microglial Nr4a1, neuronal C3 deposition, excessive hippocampal synaptic pruning, and depression-like behaviors in mice. Its experimental framework separates peripheral TMJ pathology from downstream central immune and synaptic changes, highlighting Nr4a1 and C3 as candidate points for mechanistic investigation.

• NIH/3T3 Cells: Recovery, Culture, and QC

  2026-09-22

  This guide provides a practical recovery, expansion, and quality-control workflow for NIH/3T3 Cells (BC1017), an adherent mouse fibroblast starting population supplied as a cryopreserved vial. It supports planning for cell transfection studies, viral proliferation research, and oncogene research, but the product dossier does not establish quantitative assay performance, clinical suitability, or viral permissiveness.

601 records 6/41 page Previous Next First page 上5页 678910 下5页 Last page